Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis

Emmanuelle Lapointe; Bahar Moghaddam; Krista Barclay; Anthony L. Traboulsee; Peter Neufeld

doi:10.1017/cjn.2018.325

Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis

Emmanuelle Lapointe, Bahar Moghaddam, Krista Barclay, Anthony L. Traboulsee, Peter Neufeld

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	712-714
Number of pages	3
Journal	Canadian Journal of Neurological Sciences
Volume	45
Issue number	6
DOIs	https://doi.org/10.1017/cjn.2018.325
State	Published - 1 Nov 2018
Externally published	Yes

Keywords

Immunology
Multiple sclerosis
Patient safety

Access to Document

10.1017/cjn.2018.325

Cite this

@article{33f300f39b98482b93faa5cf791caf02,

title = "Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis",

keywords = "Immunology, Multiple sclerosis, Patient safety",

author = "Emmanuelle Lapointe and Bahar Moghaddam and Krista Barclay and Traboulsee, {Anthony L.} and Peter Neufeld",

year = "2018",

month = nov,

day = "1",

doi = "10.1017/cjn.2018.325",

language = "English",

volume = "45",

pages = "712--714",

journal = "Canadian Journal of Neurological Sciences",

issn = "0317-1671",

publisher = "Cambridge University Press",

number = "6",

}

TY - JOUR

T1 - Goodpasture's Syndrome Following Alemtuzumab Therapy in Multiple Sclerosis

AU - Lapointe, Emmanuelle

AU - Moghaddam, Bahar

AU - Barclay, Krista

AU - Traboulsee, Anthony L.

AU - Neufeld, Peter

PY - 2018/11/1

Y1 - 2018/11/1

KW - Immunology

KW - Multiple sclerosis

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=85056657584&partnerID=8YFLogxK

U2 - 10.1017/cjn.2018.325

DO - 10.1017/cjn.2018.325

M3 - Letter

C2 - 30277178

AN - SCOPUS:85056657584

SN - 0317-1671

VL - 45

SP - 712

EP - 714

JO - Canadian Journal of Neurological Sciences

JF - Canadian Journal of Neurological Sciences

IS - 6

ER -